Nilotinib Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials

Nilotinib, for Patients With CML-CP, CML-AP, or CML-BC
Condition:   Chronic Myelogenous Leukemia (CML) Intervention:   Drug: Nilotinib Sponsor:   Novartis Pharmaceuticals Available (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 19, 2020 Category: Research Source Type: clinical trials

MAP to Provide Access to Nilotinib, for Patients With HES
Condition:   Hypereosinophilic Syndrome (HES) Intervention:   Drug: Nilotinib Sponsor:   Novartis Pharmaceuticals Available (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 5, 2020 Category: Research Source Type: clinical trials

Rapid Analysis and Response Evaluation of Combination Anti-Neoplastic Agents in Rare Tumors (RARE CANCER) Trial: RARE 1 Nilotinib and Paclitaxel
Condition:   Neoplasms Intervention:   Drug: Nilotinib and Paclitaxel Sponsor:   National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 29, 2020 Category: Research Source Type: clinical trials

Rapid Analysis and Response Evaluation of Combination Anti-Neoplastic Agents in Rare Tumors (RARE CANCER) Trial: RARE 1 Nilotinib and Paclitaxel
Condition:   Neoplasms Interventions:   Drug: Nilotinib;   Drug: Paclitaxel Sponsor:   National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 29, 2020 Category: Research Source Type: clinical trials